INNV

Innovage Holding Corp. Health Care Services-Health Services Russell 3000
$9.19Close $1.3BMarket cap $3.99 – $12.1152-week range Nov 3, 2026Next report · after the close

Highlights

Strengths

  • Leading the market RS 82 · stronger than 82% of stocks over 12 months

Cautions

  • Trend not confirmed 6 of 8 conditions · under the 150/200-day, under the 50-day
  • Results soon Nov 3, 2026, in 2 days
  • Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Jun 30, 2026 · filed Sep 9, 2026
Off 12-month high 24%
1wk down 3.8% price change
1mo up 4.4% price change
12-month return up 99% market up 11% · its own up 80%
F-score 6 / 9 Mixed
Altman Z″ 0.39 Elevated risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 5.3× price / book
Earnings yield up 0.2% EBIT / enterprise value
Cheaper than 39% of the market · expensive
Revenue growth up 16% year on year
EPS growth — latest quarter
Sales growth up 18% latest quarter · +3 pts
ROE down 1% return on equity
Free cash margin up 5% $50.4M FCF
D/E 0.19 long-term debt / equity
Net debt / EBITDA -2.2× net cash
Interest cover —EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • short-term liquidity weakened
  • issued more shares
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • reduced long-term debt
  • gross margin widened
  • assets working harder

Repair signals

  • Long-term debt down 21% ($0.1B → $0.0B)
  • Gross margin 18.0% → 23.0%

Trade setup

ATR% 4.1% $0.37 a day · 2×ATR $8.44
RS 82 / 99 vs the universe
Trend 6 / 8 under the 150/200-day, under the 50-day
Relative volume 1.0× vs 50-day average
Up/down volume 0.75 50 sessions
Implied move — no option chain · report Nov 3, 2026
Trend template · 6 of 8
  • Price above the 150 and 200-day averages: fails
  • Price above the 50-day average: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
Last reported Sep 8, 2026
Last shock Sep 23, 2026-16% in one session17.4× volumeon an SEC filing+2% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $989.7M +16% on FY2025
$0 $1B FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · $637.8M FY2022 · $698.6M FY2023 · $688.1M FY2024 · $763.9M FY2025 · $853.7M FY2026 · $989.7M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$2.5M
-$50M $0 FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · -$44.0M FY2022 · -$6.5M FY2023 · -$40.7M FY2024 · -$21.3M FY2025 · -$30.3M FY2026 · -$2.5M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $50.4M +89% on FY2025
-$50M $0 $100M FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · -$25.1M FY2022 · -$10.9M FY2023 · -$3.1M FY2024 · -$44.8M FY2025 · $26.6M FY2026 · $50.4M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 23%
  • Net -0%
  • Free cash 5%
-10% 0% 25% FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · Net -7% · Free cash -4% FY2022 · Gross 19% · Net -1% · Free cash -2% FY2023 · Gross 15% · Net -6% · Free cash -0% FY2024 · Gross 17% · Net -3% · Free cash -6% FY2025 · Gross 18% · Net -4% · Free cash 3% FY2026 · Gross 23% · Net -0% · Free cash 5%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $52.4M net cash
  • Cash
  • Long-term debt
$0 $250M FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · Cash $201.5M · Long-term debt $71.6M FY2022 · Cash $184.4M · Long-term debt $68.2M FY2023 · Cash $127.2M · Long-term debt $64.8M FY2024 · Cash $56.9M · Long-term debt $61.5M FY2025 · Cash $64.1M · Long-term debt $57.5M FY2026 · Cash $97.9M · Long-term debt $45.5M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 136.02m +0.4% since FY2021
136.12m 135.44m FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · 135.52m FY2022 · 135.53m FY2023 · 135.64m FY2024 · 136.12m FY2025 · 135.44m FY2026 · 136.02m
  FY2021Jun 30, 2021 FY2022Jun 30, 2022 FY2023Jun 30, 2023 FY2024Jun 30, 2024 FY2025Jun 30, 2025 FY2026Jun 30, 2026
Revenue $637.8M $698.6M $688.1M $763.9M $853.7M $989.7M
Gross margin — 19% 15% 17% 18% 23%
Operating income -$12.3M -$4.4M -$49.4M -$23.2M -$29.8M $2.6M
Net income -$44.0M -$6.5M -$40.7M -$21.3M -$30.3M -$2.5M
Net margin -7% -1% -6% -3% -4% -0%
Earnings per share -$0.36 -$0.05 -$0.30 -$0.16 -$0.22 -$0.02
Free cash flow -$25.1M -$10.9M -$3.1M -$44.8M $26.6M $50.4M
Free cash margin -4% -2% -0% -6% 3% 5%
Cash $201.5M $184.4M $127.2M $56.9M $64.1M $97.9M
Long-term debt $71.6M $68.2M $64.8M $61.5M $57.5M $45.5M
Shareholders' equity $334.6M $332.4M $296.3M $269.3M $235.0M $235.6M
Shares outstanding 135.52m 135.53m 135.64m 136.12m 135.44m 136.02m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Sep 9, 2026 Annual ↗ Jun 30, 2026 71d
May 8, 2026 Quarterly ↗ Mar 31, 2026 38d
Feb 3, 2026 Quarterly ↗ Dec 31, 2025 34d
Nov 4, 2025 Quarterly ↗ Sep 30, 2025 35d
Sep 9, 2025 Annual ↗ Jun 30, 2025 71d
May 6, 2025 Quarterly ↗ Mar 31, 2025 36d
Feb 4, 2025 Quarterly ↗ Dec 31, 2024 35d
Nov 5, 2024 Quarterly ↗ Sep 30, 2024 36d
Sep 10, 2024 Annual ↗ Jun 30, 2024 72d
May 7, 2024 Quarterly ↗ Mar 31, 2024 37d
Feb 6, 2024 Quarterly ↗ Dec 31, 2023 37d
Nov 7, 2023 Quarterly ↗ Sep 30, 2023 38d

Current reports